ID: ALA3219981

Max Phase: Preclinical

Molecular Formula: C17H28F2OS

Molecular Weight: 318.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)=CCC/C(C)=C/CC/C(C)=C/CSC(F)(F)CO

Standard InChI:  InChI=1S/C17H28F2OS/c1-14(2)7-5-8-15(3)9-6-10-16(4)11-12-21-17(18,19)13-20/h7,9,11,20H,5-6,8,10,12-13H2,1-4H3/b15-9+,16-11+

Standard InChI Key:  NJICZKNETDTFNP-XGGJEREUSA-N

Associated Targets(Human)

Isoprenylcysteine carboxyl methyltransferase 596 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 318.47Molecular Weight (Monoisotopic): 318.1829AlogP: 5.72#Rotatable Bonds: 10
Polar Surface Area: 20.23Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.50CX Basic pKa: CX LogP: 5.57CX LogD: 5.57
Aromatic Rings: 0Heavy Atoms: 21QED Weighted: 0.52Np Likeness Score: 1.03

References

1. Majmudar JD, Morrison-Logue A, Song J, Hrycyna CA, Gibbs RA.  (2012)  Identification of a novel nanomolar inhibitor of hIcmt via a carboxylate replacement approach,  (9): [10.1039/C2MD20108A]

Source